BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Prognosis
40 results:

  • 1. Prognostic Prediction Value and Biological Functions of Non-Apoptotic Regulated Cell Death Genes in lung Adenocarcinoma.
    Li HL; Wang JX; Dai HW; Liu JJ; Liu ZY; Zou MY; Zhang L; Wang WR
    Chin Med Sci J; 2023 Sep; 38(3):178-190. PubMed ID: 37622313
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Measuring direct non-medical burden among patients with advanced non-small cell lung cancer in China: is there a difference in health status?
    Xia Y; Chen Y; Chen J; Gan Y; Su C; Zhang H; Long E; Yan F; Yang Y
    Front Public Health; 2023; 11():1090623. PubMed ID: 37213608
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Suicide Risk Among Individuals Diagnosed With cancer in the US, 2000-2016.
    Hu X; Ma J; Jemal A; Zhao J; Nogueira L; Ji X; Yabroff KR; Han X
    JAMA Netw Open; 2023 Jan; 6(1):e2251863. PubMed ID: 36662522
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Promoter methylation levels of
    Mashayekhi M; Asadi M; Hashemzadeh S; Vahedi A; Shanehbandi D; Al-Omar AF; Akbari M; Raeisi M
    Horm Mol Biol Clin Investig; 2023 Jun; 44(2):145-152. PubMed ID: 36584330
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A prognostic risk model based on DNA methylation levels of genes and lncRNAs in lung squamous cell carcinoma.
    Wang W; Xiang M; Liu H; Chu X; Sun Z; Feng L
    PeerJ; 2022; 10():e13057. PubMed ID: 35356464
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.
    Yoshida C; Yokomise H; Ibuki E; Go T; Haba R; Kadota K
    Gen Thorac Cardiovasc Surg; 2022 May; 70(5):455-462. PubMed ID: 35050467
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. prognosis-related autophagy genes in female lung adenocarcinoma.
    Liu Z; Zhang K; Zhao Z; Qin Z; Tang H
    Medicine (Baltimore); 2022 Jan; 101(1):e28500. PubMed ID: 35029906
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell lung cancer Treated with Stereotactic Radiotherapy.
    Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
    Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell lung cancer: Relation to Different Hematologic Indices.
    Zahran AM; Hetta HF; Zahran ZAM; Rashad A; Rayan A; Mohamed DO; Elhameed ZAA; Khallaf SM; Batiha GE; Waheed Y; Muhammad K; Nafady-Hego H
    J Immunol Res; 2021; 2021():3241150. PubMed ID: 34671684
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
    Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
    BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
    Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
    Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination.
    Zarogoulidis P; Christakidis V; Petridis D; Sapalidis K; Kosmidis C; Vagionas A; Perdikouri EI; Hohenforst-Schmidt W; Huang H; Petanidis S; Tsakiridis K; Baka S; Romanidis K; Zaric B; Kovacevic T; Stojsic V; Sarcev T; Bursac D; Kukic B; Boukovinas I; Tolis C; Sardeli C
    Expert Rev Respir Med; 2021 May; 15(5):675-679. PubMed ID: 33275458
    [No Abstract]    [Full Text] [Related]  

  • 13. Soluble intercellular cell adhesion molecule-1 in lung cancer: A meta-analysis.
    Wu M; Tong X; Wang D; Wang L; Fan H
    Pathol Res Pract; 2020 Oct; 216(10):153029. PubMed ID: 32853940
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Initial neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with inoperable locally advanced non-small-cell lung cancer.
    Sun S; Qu Y; Wen F; Yu H
    Biomark Med; 2020 Oct; 14(14):1341-1352. PubMed ID: 32808809
    [No Abstract]    [Full Text] [Related]  

  • 15. External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
    Barth DA; Brenner C; Riedl JM; Prinz F; Klocker EV; Schlick K; Kornprat P; Lackner K; Stöger H; Stotz M; Gerger A; Pichler M
    Cancer Med; 2020 Aug; 9(15):5473-5479. PubMed ID: 32537935
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association Between Pretreatment Serum Apolipoprotein A1 and prognosis of Solid Tumors in Chinese Population: A Systematic Review and Meta-Analysis.
    Wu J; Zhang C; Zhang G; Wang Y; Zhang Z; Su W; Lyu J
    Cell Physiol Biochem; 2018; 51(2):575-588. PubMed ID: 30466099
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic Value of White Blood Cells Detected for the First Time After Adjuvant Chemotherapy in Primary Operable Non-Small Cell lung cancer.
    Hao L; Zhang J; Di Y; Tan Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818802813. PubMed ID: 30295143
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Systemic Immune-inflammation Index Predicts Survival of Patients After Curative Resection for Non-small Cell lung cancer.
    Tomita M; Ayabe T; Maeda R; Nakamura K
    In Vivo; 2018; 32(3):663-667. PubMed ID: 29695576
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.
    Churilla TM; Ballman KV; Brown PD; Twohy EL; Jaeckle K; Farace E; Cerhan JH; Anderson SK; Carrero XW; Garces YI; Barker FG; Deming R; Dixon JG; Burri SH; Chung C; Ménard C; Stieber VW; Pollock BE; Galanis E; Buckner JC; Asher AL
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1173-1178. PubMed ID: 28939223
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.